期刊文献+

冠状动脉病变形态学与急性心肌梗死直接经皮冠状动脉介入治疗后无复流的关系 被引量:2

The relationship between morphology of coronary artery pathological changes and no-reflow phenomenon after primary percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨冠状动脉病变形态学与急性ST段抬高型心肌梗死(STEAMI)患者直接经皮冠状动脉内介入治疗(PCI)后无复流的关系。方法回顾性分析自2001年3月-2004年11月410例STEAMI患者直接PCI后的临床和造影资料,无复流患者51例,由其余359例直接PCI后TIMI3级冠脉前向血流者中随机抽取60例作为正常血流组。结果无复流的发生率为12.44%。分析表明:两组在几乎完全闭塞、血栓、钙化、长病变等造影发现的罪犯血管形态学改变中存在显著性差异。结论STEAMI患者如果在造影时发现罪犯血管存在几乎完全闭塞、血栓、钙化、长病变等形态学改变,则行直接PCI后无复流的发生率显著增加。 Objective To study the relationship between morphology of coronary artery pathological changes and no-reflow phenomenon after primary percutaneous coronary intervention (PCI). Methods Clinical and angiographic data of 410 patients with with ST segment elevation acute myocardial infarction (STEAMI) after primary PCI were retrospectively analyzed between Mar 2001 and Nov 2004, 51 patients of them were with no-reflow phenomenon, and 60 patients were randomized from the rest 359 patients with coronary antergrade flow TIMI 3 class which were as normal flow group. Results Incidence of the no-reflow phenomenon was 12.44~, the analysis showed that significant difference were found between the two groups in the following changes of morphology such as: almost complete occlusion, thrombus, calcification and long pathological changes. Conclusion If the following morphological changes such as: almost complete occlusion, thrombus, calification, and long pathological changes were found in infarction relative artery (IRA), incidence of no-reflow phenomenom increased after primary PCI with STEAMI.
出处 《中国介入影像与治疗学》 CSCD 2006年第4期274-277,共4页 Chinese Journal of Interventional Imaging and Therapy
关键词 病变形态学 急性心肌梗死 经皮冠状动脉介入治疗 无复流 Morphology of pathological changes Acute myocardial infarction Percutaneous coronary intervention Noreflow
  • 相关文献

参考文献2

二级参考文献6

  • 1杨新春 王乐丰 佟子川 等.急性心肌梗死症状发作-首次球囊扩张时间和症状发作--进入导管室时间与左心室射血分数和肌酸激酶MB同工酶的关系[J].中国循环杂志,2002,17:77-77.
  • 2Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in myocardial infarction(TIMI) trial, Phase I: A comparision between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation
  • 3Sone T, Okumura K, Tsuboi H, et al. Angiographic no-flow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. JACC, 2000, 36:1202-1209.
  • 4Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of ""no flow"" after percutaneous coronary intervention. Circulation, 1994,89:2514-2518.
  • 5Abbo KM, Doris M, Glazier S, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol, 1995,75:778-782.
  • 6Baumgent D, Haude M, Goerke G, et al. Improved assessment of coronary stenosis severity using the relative flow velocity reserve. Circulation, 1998,98:40-46.

共引文献60

同被引文献22

  • 1王梅,王海燕.缺血性肾病发病机制和预后[J].中国实用内科杂志,2005,25(10):865-866. 被引量:17
  • 2蒋雄京,吴海英,张慧敏,何作祥,郑德裕,刘国仗,惠汝太,刘力生.经皮肾动脉支架术治疗肾血管性高血压的临床结果[J].中国循环杂志,2006,21(2):89-92. 被引量:23
  • 3Mwipatayi BP,Beningfield SJ,White LE,et al.A review of the current treatment of renal artery stenosis.Eur J Vasc Endovasc Surg,2005,29(5):479-488.
  • 4Chesebro JH,Knatterud G,Roberts R,et al.Thrombolysis in myocardial infarction (TIMI) trial,phase i:a comparison between intravenous tissue plasminogen activator and intravenous streptokinase.Clinical findings through hospital discharge.Circulation,1987,76(1):142-154.
  • 5Rezkalla SH,Kloner RA.No-reflow phenomenon.Circulation,2002,105(5):656-662.
  • 6Kunichika H,Ben-Yehuda O,Lafitte S,et al.Effects of glycoprotein Ⅱb/Ⅲa inhibition on microvascular flow after coronary reperfusion.A quantitative myocardial contrast echocardiography study.J Am Coll Cardiol,2004,43(2):276-283.
  • 7Gibson CM,Morrow DA,Murphy SA,et al.A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction,ischemia,and inflammation among antiplatelet and antithrombotic agents:the PROTECT-TIMI-30 trial.J Am Coll Cardiol,2006,47(12):2364-2373.
  • 8Rezkalla SH,Kloner RA.No-relow phenomenon.Circulation,2002,105:656-662.
  • 9Tanaka A,Kawarabayashi T,Nishibori Y,et al.No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction.Circulation,2002,105:2148-2152.
  • 10Takahashi T,Anzai T,Yoshikawa T,et al.Absence of preinfarction angina is associated with a risk of no-reflow phenomenon after primary coronary angioplasty for a first anterior wall no-reflow phenonmennon.Int J Cardial,2000,75:253-260.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部